Technological innovations are accelerating at an unprecedented rate, paving the way for revolutionary new discoveries in all areas of human endeavor. Previously insoluble problems are being solved, and Boston TransTec is at the forefront of the wave.
Boston TransTec is now leveraging the latest scientific advances to radically improve the design of cardiac and other medical devices, giving patients globally not only hope but a cure.
We will launch our business by first restoring cardiac functionality, stop degradation into heart failure or treat it to halt its progress, and improve patient quality of life.
Dr. Tkebuchava decided to specialize in cardiac surgery to help save critically ill patients. Over many operations, however, he realized that even after technically successful open-heart surgeries, patients experienced long and painful recoveries.
He experimented with genes and stem cells and their combinations on infarcted myocardium and was impressed by the results: he clearly saw that simple, non-invasive interventions could save lives. He also recognized that although many therapeutic agents are available today, there is currently no effective mechanism for delivering them safely and effectively to target tissue.
His design for a novel delivery catheter draws not only on his experience at global centers on different cardiac surgeries and various device implantations, but also on his years of treatment and research in regenerative therapeutics.
Dr. Tkebuchava is the author of six patents and worldwide publications. He has developed and performed numerous surgical techniques for both children and adults with diverse congenital and acquired cardiovascular abnormalities as well as heart transplants.
He currently runs Boston TransTec in Boston and an American Center of Regenerative Medicine – RegMed Georgia – in Tbilisi, Georgia, where he treats patients with severe conditions worldwide.
Yoelena brings extensive experience from her prior role as a management consultant at Deloitte, where she advised Fortune 500 clients in the Life Sciences and Health Care sectors.
Her project experience spans Operating Model Design, Go-to-Market and Business Model Strategy, Digital Transformation, and Change Management, leading project workstreams under tight deadlines to consistently deliver high-impact solutions to her clients.
She holds a BA in Philosophy, Politics, and Economics from the University of Pennsylvania, with a concentration in Legal Studies and Ethics at the Wharton School.
The Viper™ Catheter is currently limited by United States law to investigational use and is not approved for sale or commercial use at this time.
